SGLT-2 inhibitors: Oral medications that work by helping the kidneys remove excess glucose from the body through urine
Specifically, body mass decreased by 9% after three months, 5% after six months, and 4% after 12 months
It is also approved kosher and does not contain any major allergens
Certain medications also combine GLP-1 action with hormones like Tirzepatide, which work by targeting both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
[,] Long-term safety considerations for tirzepatide While Tirzepatide shows great promise, long-term safety remains an important consideration: Chronic Toxicity: Monitoring for potential effects on liver, kidney, and pancreatic function is advised, especially in patients with pre-existing conditions
Dietary guidelines for chinese residents (2016): comments and comparisons